Jens Juul Holst

Jens Juul Holst

Professor

ORCID: 0000-0001-6853-3805

Publication year:
All
11 - 20 out of 32Page size: 10
Sort by: Title
  1. Published

    Non-insulin-dependent diabetes mellitus - new drugs?

    Holst, Jens Juul, 1997, In: Drug Discovery Today. 2, p. 128-129

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance.

    Christiansen, E., Tibell, A., Vølund, A., Holst, Jens Juul, Rasmussen, K., Schäffer, L. & Madsbad, S., 1997, In: J. Clin. Endocrinol. Metab.. 82, p. 2299-2307

    Research output: Contribution to journal › Journal article › Research

  3. Published

    Holder GLP-1 som nyt terapeutisk princip i diabetesbehandlingen hvad det lovede?

    Holst, Jens Juul, 1997, In: Tidsskrift for Diabetesbehandling. 2(7), p. 16-22

    Research output: Contribution to journal › Journal article › Research

  4. Published

    Glucose absorption and the release of insulin, gastric inhibitory polypeptide, and glucagon-like peptide-1 in patients after total colectomy.

    Palnæs Hansen, C., Andreassen, J. & Holst, Jens Juul, 1997, In: Scandinavian Journal of Gastroenterology. 32, p. 473-477

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans

    Flint, A., Raben, A., Holst, Jens Juul & Astrup, A., 1997, International journal of obesity. 21 ed. European Association for the Study of Obesity, p. 16 1 p.

    Research output: Chapter in Book/Report/Conference proceeding › Article in proceedings › Research

  6. Published

    Glucagon-like peptide-1 7-36amide and peptide YY have additive inhibitory effects on gastric acid secretion in man.

    Wettergren, A., Maina, P., Boesby, S. & Holst, Jens Juul, 1997, In: Scandinavian Journal of Gastroenterology. 32, p. 552-555

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Glucagon-like peptide-1 (GLP-17-36amide) reduces hepatic glucose production indirectly through changes in insulin and glucagon secretion.

    Larsson, H., Holst, Jens Juul & Ahrén, B., 1997, In: Acta Phys. Scand.. 160, p. 413-422

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes.

    Nauck, M. A., Holst, Jens Juul, Willms, B. & Schmiegel, W., 1997, In: Exp. Clin. Endocrinol. Diabetes. 105, p. 187-195

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

    Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, Jens Juul, Ørskov, Cathrine, Ritzel, R. & Schmiegel, W. H., Nov 1997, In: American Journal of Physiology (Consolidated). 273, 5 Pt 1, p. E981-8

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity.

    Näslund, E., Grybäck, P., Hellström, P. M., Jacobsson, H., Holst, Jens Juul, Theodorsson, E. & Backmann, L., 1997, In: International Journal of Obesity. 21, p. 387-392

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 4207